XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Issues regarding biodefense, specifically regarding national security and medical countermeasure development and manufacture. Issues regarding medical countermeasure stockpiling. Issues regarding the HHS BARDA program and increasing BARDA funding via the Public Health and Social Services Emergency Fund in both the House and Senate economic stimulus bills and the LHHS FY09 omnibus bill. Issues regarding flexible biopharmaceutical manufacturing related to biodefense and increasing HHS BARDA funding in any funding vehicle moving forward (economic stimulus bills and/or LHHS FY09 omnibus bill) regarding the creation of national centers of excellence for flexible manufacturing of medical countermeasures. H.R. 7110, "Job Creation and Unemployment Relief Act of 2008," provisions relating to inserting HHS BARDA funding via the Public Health and Social Services Emergency Fund.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA New | — |
| PATRICK JEROME SCANNON | — |
Medical/Disease Research/Clinical Labs MED
Issues regarding anti-botulism toxin. Issues related to biotechnology research and biotechnology workforce education via the creation of National Life Sciences Academy in CA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA New | — |
| PATRICK JEROME SCANNON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.